A potential new biomarker for predicting future cognitive resilience versus decline among people with early Alzheimer's disease is described in Nature Medicine. This protein signature may improve the ...

Fighting Alzheimer’s disease is a race against time. By the time most patients are diagnosed and treated, their cognitive symptoms have already advanced significantly. New research, though, pinpoints ...

Faster motor and cognitive progression of Parkinson disease was found in patients with higher baseline cerebrospinal fluid neurofilament heavy levels. Higher cerebrospinal fluid (CSF) neurofilament ...

Some scientists believe that toxic tau fibrils hop between synapses to spread throughout the brain, prompted by Aβ aggregates and overactive neurons. New imaging and biomarker data add weight to this ...

Scientists now have a slew of biomarkers, both fluid assays and PET ligands, that distinguish Alzheimer’s from other neurodegenerative diseases, such as frontotemporal dementia, Parkinson’s, and ...